Patient engagement: what comes next?


In a recent guest column in Clinical Leader, Barbara Lopez Kunz, global chief executive of DIA writes about what is next in patient engagement. She lists PREFER among organisations that drive research and policy activities for guidance on patient-centricity in benefit-risk assessment and systematic incorporation of data on patient perspectives in product approval applications.

In recent years, the DIA and organisations have taken a number of initiatives that has helped provide insights into patient engagement, including the recently launched Innovative Medicines Initiative PARADIGM project (Patients Active in Research and Dialogues for an Improved Generation of Medicines).

Read the column

Last modified: 2021-11-10